NTI Secondary Trading Notice 31/01/23 download Created with Sketch. 91.96KB Share NTI Application for quotation of securities - NTI 31/01/23 download Created with Sketch. 29.23KB Share NTI Top 20 securityholders 31/01/23 download Created with Sketch. 68.66KB Share NTI Distribution Schedule 31/01/23 download Created with Sketch. 63.42KB Share NTI Application for quotation of securities - NTI 31/01/23 download Created with Sketch. 26.89KB Share NTI Quarterly Activities/Appendix 4C Cash Flow Report 30/01/23 PRICE SENSITIVE download Created with Sketch. 711.15KB Share NTI HREC Approval for Phase I/II PANDAS/PANS Clinical Trial 27/01/23 PRICE SENSITIVE download Created with Sketch. 207.61KB Share NTI Secondary Trading Notice 24/01/23 download Created with Sketch. 91.93KB Share NTI Application for quotation of securities - NTI 24/01/23 download Created with Sketch. 26.47KB Share NTI Notice of Quarterly Investor Conference Call 24/01/23 download Created with Sketch. 99.94KB Share NTI NTI Granted FDA Pre-IND Meeting for NTI164 in ASD 19/01/23 PRICE SENSITIVE download Created with Sketch. 173.92KB Share NTI Extension of Offers under Prospectus 13/01/23 download Created with Sketch. 103.75KB Share NTI Change of Director's Interest Notice x2 28/12/22 download Created with Sketch. 208.77KB Share NTI Notification regarding unquoted securities - NTI 23/12/22 download Created with Sketch. 38.72KB Share NTI Application for quotation of securities - NTI 23/12/22 download Created with Sketch. 24.92KB Share NTI Proposed issue of securities - NTI 22/12/22 download Created with Sketch. 37.3KB Share NTI Target Market Determination - Option Offer 22/12/22 download Created with Sketch. 200.48KB Share NTI Disclosure Document 22/12/22 PRICE SENSITIVE download Created with Sketch. 303.07KB Share NTI Application for quotation of securities - NTI 21/12/22 download Created with Sketch. 24.79KB Share NTI Final Director's Interest Notice 21/12/22 download Created with Sketch. 132.18KB Share NTI Passing of a Director 21/12/22 download Created with Sketch. 130.75KB Share NTI Commencement of Phase II/III ASD Clinical Trial 19/12/22 PRICE SENSITIVE download Created with Sketch. 179.16KB Share NTI Results of Meeting 30/11/22 download Created with Sketch. 163.66KB Share NTI 2022 Annual General Meeting Presentation 30/11/22 download Created with Sketch. 2.42MB Share NTI Chairman Address to 2022 Annual General Meeting 30/11/22 download Created with Sketch. 112.32KB Share NTI Change of Director's Interest Notice x 2 22/11/22 download Created with Sketch. 286.31KB Share NTI Application for quotation of securities - NTI 18/11/22 download Created with Sketch. 28.36KB Share NTI NTI Receives HREC/TGA Approval for Phase II/III ASD Trial 17/11/22 PRICE SENSITIVE download Created with Sketch. 271.47KB Share NTI Secondary Trading Notice 07/11/22 download Created with Sketch. 201.52KB Share NTI Application for quotation of securities - NTI 07/11/22 download Created with Sketch. 28.53KB Share NTI Application for quotation of securities - NTI 07/11/22 download Created with Sketch. 26.06KB Share NTI Becoming a substantial holder 04/11/22 download Created with Sketch. 301.78KB Share NTI Notice of Annual General Meeting/Proxy Form 31/10/22 download Created with Sketch. 1.11MB Share NTI Annual Report (Typeset) 31/10/22 download Created with Sketch. 3.32MB Share NTI Neurotech Receives $1.2M R&D Tax Rebate 31/10/22 PRICE SENSITIVE download Created with Sketch. 133.45KB Share NTI Quarterly Activities/Appendix 4C Cash Flow Report 31/10/22 PRICE SENSITIVE download Created with Sketch. 340.9KB Share NTI Reinstatement to Quotation 28/10/22 PRICE SENSITIVE download Created with Sketch. 409.65KB Share NTI Investor Presentation 28/10/22 download Created with Sketch. 2.16MB Share NTI Proposed issue of securities - NTI 28/10/22 download Created with Sketch. 33.51KB Share NTI Neurotech Completes $9.0M Placement 28/10/22 PRICE SENSITIVE download Created with Sketch. 280.19KB Share NTI Suspension From Official Quotation 27/10/22 PRICE SENSITIVE download Created with Sketch. 585.19KB Share NTI 20 Week Data Shows Significant Improvement For ASD Children 26/10/22 PRICE SENSITIVE download Created with Sketch. 465.94KB Share NTI Application for quotation of securities - NTI 25/10/22 download Created with Sketch. 26.45KB Share NTI Trading Halt 25/10/22 PRICE SENSITIVE download Created with Sketch. 501.3KB Share NTI Upcoming Presentation at South-West Connect ASX Showcase 19/10/22 download Created with Sketch. 1.81MB Share NTI New Phase I/II Clinical Trial in Children with PANDAS/PANS 17/10/22 PRICE SENSITIVE download Created with Sketch. 187.64KB Share NTI Application for quotation of securities - NTI 12/10/22 download Created with Sketch. 29.21KB Share NTI Proposed issue of securities - NTI 11/10/22 download Created with Sketch. 27.59KB Share NTI Autism Spectrum Disorder Phase I/II Clinical Trial Update 15/09/22 download Created with Sketch. 142.98KB Share NTI NTI to Present at ASX Small to Mid-Cap Investor Conference 09/09/22 download Created with Sketch. 97.92KB Share NTI Initial Director's Interest Notice 08/09/22 download Created with Sketch. 136.04KB Share NTI Application for quotation of securities - NTI 06/09/22 download Created with Sketch. 29.17KB Share NTI Neurotech to present at E&P Small Cap Healthcare Conference 06/09/22 download Created with Sketch. 2.26MB Share NTI Executive Change 01/09/22 PRICE SENSITIVE download Created with Sketch. 104.84KB Share NTI Appendix 4G and Corporate Governance Statement 31/08/22 download Created with Sketch. 398.36KB Share NTI Appendix 4E & Annual Report 31/08/22 PRICE SENSITIVE download Created with Sketch. 839KB Share NTI Final Director's Interest Notice x2 16/08/22 download Created with Sketch. 1.44MB Share NTI Proposed issue of securities - NTI 16/08/22 download Created with Sketch. 26.9KB Share NTI Proposed issue of securities - NTI 16/08/22 download Created with Sketch. 31.02KB Share NTI Consultant Appointment and Board Changes 16/08/22 download Created with Sketch. 148.22KB Share NTI Change of Director's Interest Notice 03/08/22 download Created with Sketch. 605.46KB Share NTI Quarterly Activities/Appendix 4C Cash Flow Report 29/07/22 PRICE SENSITIVE download Created with Sketch. 337.34KB Share NTI Q&A on NTI164 Breakthrough Clinical Trial Results in ASD 22/07/22 PRICE SENSITIVE download Created with Sketch. 143.91KB Share NTI Initial Director's Interest Notice 13/07/22 download Created with Sketch. 119.19KB Share NTI Investor Presentation 08/07/22 download Created with Sketch. 15.59MB Share NTI Investor Webinar 08/07/22 download Created with Sketch. 99.41KB Share NTI Reinstatement to Official Quotation 08/07/22 PRICE SENSITIVE download Created with Sketch. 415.41KB Share NTI BREAKTHROUGH RESULTS WITH NTI164 IN PAEDIATRIC ASD 08/07/22 PRICE SENSITIVE download Created with Sketch. 333.24KB Share NTI Extension to Voluntary Suspension 07/07/22 PRICE SENSITIVE download Created with Sketch. 66.46KB Share NTI Suspension from Official Quotation 06/07/22 PRICE SENSITIVE download Created with Sketch. 478.53KB Share NTI Trading Halt 04/07/22 PRICE SENSITIVE download Created with Sketch. 468.39KB Share NTI Neurotech CEO to Present at Gold Coast Investment Showcase 22/06/22 download Created with Sketch. 6.56MB Share NTI Proposed issue of securities - NTI 09/06/22 download Created with Sketch. 26.77KB Share NTI Preclinical Success with Targeted Combination Therapies 09/06/22 PRICE SENSITIVE download Created with Sketch. 211.17KB Share NTI Investor Webinar Presentation 03/06/22 download Created with Sketch. 2.4MB Share NTI Neurotech CEO to Present at Bioshares Conference 12/05/22 download Created with Sketch. 1.44MB Share NTI Key Development in Current Paediatric ASD Study 12/05/22 download Created with Sketch. 122.68KB Share NTI Quarterly Activities/Appendix 4C Cash Flow Report 29/04/22 PRICE SENSITIVE download Created with Sketch. 264.61KB Share NTI Q&A With Company CEO, Dr Alex Andrews 13/04/22 download Created with Sketch. 168.68KB Share NTI Successful Landmark Study in Paediatric ASD 05/04/22 PRICE SENSITIVE download Created with Sketch. 242.62KB Share NTI Notification regarding unquoted securities - NTI 10/03/22 download Created with Sketch. 37.94KB Share NTI Medicinal Cannabis Presentation 10/03/22 download Created with Sketch. 136.55KB Share NTI Proposed issue of securities - NTI 03/03/22 download Created with Sketch. 33.94KB Share NTI Appointment of Chief Executive Officer 03/03/22 PRICE SENSITIVE download Created with Sketch. 155.56KB Share NTI Appendix 4D and Half Year Accounts 24/02/22 PRICE SENSITIVE download Created with Sketch. 1.64MB Share NTI Quarterly Activities/Appendix 4C Cash Flow Report 31/01/22 PRICE SENSITIVE download Created with Sketch. 959.81KB Share NTI Application for quotation of securities - NTI 24/01/22 download Created with Sketch. 24.92KB Share NTI Change of Registry Address 20/12/21 download Created with Sketch. 152.9KB Share NTI Change of Director's Interest Notice x 2 13/12/21 download Created with Sketch. 309.99KB Share NTI Notification regarding unquoted securities - NTI 13/12/21 download Created with Sketch. 23.86KB Share NTI Notification regarding unquoted securities - NTI 13/12/21 download Created with Sketch. 23.75KB Share NTI Preclinical Success with Targeted Combination Therapies 01/12/21 PRICE SENSITIVE download Created with Sketch. 321.37KB Share NTI Results of Meeting 18/11/21 download Created with Sketch. 156.42KB Share NTI Application for quotation of securities - NTI 16/11/21 download Created with Sketch. 24.92KB Share NTI Change of Director's Interest Notice 08/11/21 download Created with Sketch. 865.24KB Share NTI Quarterly Activities/Appendix 4C Cash Flow Report 29/10/21 PRICE SENSITIVE download Created with Sketch. 1.56MB Share NTI Investor Presentation 25/10/21 download Created with Sketch. 869.26KB Share NTI NTI to Present at the South-West Connect ASX Showcase 25/10/21 download Created with Sketch. 106.53KB Share NTI Successful Completion of Preclinical MS Studies 22/10/21 download Created with Sketch. 255.73KB Share NTI Annual Report (Typeset) 19/10/21 download Created with Sketch. 2.62MB Share
(20min delay)
